The outcome of a cohort of tuberculin-positive predominantly South Asian new entrants aged 16-34 to the UK: Blackburn 1989-2001

Journal of Public Health (United Kingdom)

Volumn 36, Issue 3, 2014, Pages 390-395

  Choudhury, I W ^a   West, C R ^b   Ormerod, L P ^c,d,e  

^a Brent Civic Centre   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c ROYAL BLACKBURN HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Chemoprophylaxis; Cohort study; Immigrant; Latent TB; Tuberculin positive

Indexed keywords

ADOLESCENT; ADULT; BANGLADESH; COST BENEFIT ANALYSIS; ECONOMICS; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INDIA; INTERFERON GAMMA RELEASE ASSAY; MALE; MIGRANT; PAKISTAN; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADULT; BANGLADESH; COST-BENEFIT ANALYSIS; EMIGRANTS AND IMMIGRANTS; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; INDIA; INTERFERON-GAMMA RELEASE TESTS; MALE; PAKISTAN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84939192589     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdt110     Document Type: Article

References (19)

1. Joint Tuberculosis Committee. Control and prevention of tuberculosis: a code of practice. Br Med J 1983;287:1118-21.
2. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in Britain: an updated code of practice. Br Med J 1990;300:995-9.
3. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: Code of Practice 1994. Thorax 1994;49:1193-200.
4. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000. Thorax 2000;55:887-901.
5. Ormerod LP. Tuberculosis screening and prevention in new immigrants 1983-88. Respir Med 1990;84:269-71.
6. Ormerod LP. Is immigrant screening for tuberculosis still worthwhile? J Infect 1998;37:39-40.
7. Callister M, Barringer J, Thanabalasingam S et al. Pulmonary tuberculosis among political asylum seekers screened at Heathrow airport, London 1995-9. Thorax 2002;57:152-56.
8. National Institute for Health and Clinical Excellence. Clinical guideline 117. Tuberculosis: full guideline appendix K-Health Economic models. NICE 2011. 2006, pp. 117-98.
9. National Institute for Health and Clinical Excellence. Clinical Guideline 117. Tuberculosis: full guideline appendix L-Health Economic Model. NICE 2011. 2011, pp 199-240.
10. Tuberculosis. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. National Collaborating Centre for Chronic Conditions for NICE. Royal College of Physicians of London, 2006, pp. 162-70.
11. Smeija MJ, Marchetti CA, Cook DJ et al. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 1999;CD001363.
12. Girling DJ, Chan SL. A double-blind placebo-controlled trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Resp Dis 1992;145:36-41.
13. Kumar D, Watson JM, Charlett A et al. Tuberculosis in England and Wales in 1993: results of a national survey. Thorax 1997;52: 1060-67.
14. Rose AMC, Watson JM, Graham C et al. Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax 2001;56:173-79.
15. Tuberculosis in the UK: UK tuberculosis surveillance report for the calendar year 2011. London: Health Protection Agency, 2012.
16. Singh H, Joshi M, Ormerod LP. A case control study in the Indian Subcontinent ethnic population on the effect of return visits and the subsequent development of TB. J Infect 2006;52:440-42.
17. Ormerod LP. New entrant screening for latent tuberculosis using IGRA testing alone. Thorax 2009;64(Suppl. IV):A10-11.
18. Hardy AB, Varma R, Collyns T et al. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB gold IGRA alone is more cost-effective for immigrants from high burden countries. Thorax 2010;65:178-80.
19. Pareek M, Lalvani A, Ormerod LP et al. UK Immigrant current screening misses the majority of imported latent tuberculosis: a multi-centre cohort study and cost-effectiveness analysis of improved screening. Lancet Infect Dis 2011;11(6):435-44.